GEN News Highlights: Apr 9, 2009

Investigators Persuade Human ES Cells to Become Oligodendrocytes

(Page 1 of 1)

    Scientists from the University of Wisconsin report that they have successfully generated oligodendrocytes from human embryonic stem (ES) cells that can make myelin.

    For the past decade, researchers have reportedly failed to persuade human neural stem cells to become oligodendrocytes. There has, however, been success in changing mouse ES cells into oligodendrocytes through the exposure to a protein called Sonic Hedgehog. This protein produces oligodendrocytes in the spinal cord of developing embryos.

    In the current study, which will be published in May issue of Development, the investigators found that treating human ES cells with this same protein also turns them into oligodendrocytes; they just take longer to do it, 14 weeks as opposed to the two weeks taken by mouse ES cells.

    They also report that a growth factor called Fgf2, which promotes oligodendrocyte development in mouse ES cells, actually stalls it in human ES cells.

Add GEN to your Inbox FREE!

Subscribe to our daily and weekly e-Newsletters to get our biotech news coverage delivered to your inbox.



Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

FDA on Biosimilars

How satisfied are you with progress toward bringing biosimilars to the U.S. market?

Suggest a Poll